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Bordetella pertussis is a Gram-negative bacillus 
that causes whooping cough in humans (Locht 
et al., 2001; Carbonetti, 2007). Among the viru-
lence factors produced by this bacterium, which 
are key to successful colonization of the bron-
chial epithelial cells, is the secreted adenylate 
cyclase toxin (CyaA), which attenuates the im-
mune defenses of the host locally and delays 
the development of a systemic immune response. 
CyaA assists the bacterium to evade clearance 
by phagocytic cells by suppressing both their 
chemotaxis  and  their  proinflammatory  and 
bactericidal activities (Mills, 2001; Ross et al., 
2004; Boyd et al., 2005; Vojtova et al., 2006). 
Moreover, CyaA modulates DC activation and 
differentiation in mice when co-administered 
with antigen, leading to an imbalance in cyto-
kine production, which in turn results in the 
preferential development of Th2 and Th17 cells 
(Ross et al., 2004; Boyd et al., 2005; Dunne   
et al., 2010). CyaA can also directly affect T cell 
activation  and  differentiation.  At  nanomolar 
concentrations, CyaA suppresses T cell activa-
tion and chemotaxis (Paccani et al., 2008), 
whereas at subnanomolar concentrations CyaA 
favors the differentiation of CD4+ T cells to the 
Th2 and Th17 lineages, with a concomitant 
impairment in Th1 cell development (Rossi 
Paccani et al., 2009), without affecting other 
subsets (cytotoxic T lymphocyte and regulatory 
T cell; unpublished results).
CyaA is a polypeptide chain of 1,706 aa resi-
dues belonging to the RTX (repeat in toxin) 
family of bacterial toxins. CyaA is synthesized 
as an inactive protoxin that is converted to an 
active toxin by posttranslational fatty acylation. 
The N-terminal part of the protein contains the 
catalytic domain, whereas the C-terminal part 
mediates its binding to the target cell membrane 
and delivery of the catalytic moiety into the cyto-
sol. After membrane translocation, the catalytic 
domain is activated by Ca2+/calmodulin, thereby 
acquiring the ability to effectively convert cellular 
ATP into cAMP (Karimova et al., 1998; Ladant 
and Ullmann, 1999; Hewlett et al., 2006). CyaA 
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The Bordetella pertussis adenylate cyclase toxin (CyaA) assists infection by potently sup-
pressing the host immune response. Although CyaA effectively targets T lymphocytes, its 
putative receptor on these cells is unknown. Here, we show that CyaA binds to T cells via 
the 2 integrin LFA-1 in its active conformation. CyaA clusters with LFA-1 at the immune 
synapse (IS), from which it induces the premature disengagement of LFA-1 concomitant 
with the dissipation of talin, which tethers the integrin to the underlying actin cytoskel-
eton. The CyaA-induced redistribution of LFA-1 was cAMP- and protein kinase A (PKA)–
dependent. These results not only identify LFA-1 as a CyaA receptor on T cells but unveil  
a novel mechanism of immunosuppression whereby the toxin parasitizes its interaction with 
LFA-1 to inhibit signaling at the IS through the local production of cAMP. The data also 
provide novel insights into the role of cAMP/PKA signaling in controlling the dynamics of 
the IS.
© 2011 Baldari et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it  is  available  under  a  Creative  Commons  License  (Attribution–Noncommer-
cial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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interaction contributes to the suppressive activity of CyaA by 
promoting a selective LFA-1 mediated targeting of the toxin 
to the immune synapse (IS) between T cell and APC. Recruit-
ment of CyaA to the IS, where the pathways driving T cell 
activation are coordinated, ensures an efficient poisoning of 
this signaling platform, a major effect being the rapid cAMP/
protein kinase A (PKA)–dependent disengagement of LFA-1 
from the IS.
RESULTS
Saturable binding of CyaA to T cells
The ability of CyaA to bind to T cells was assessed by flow 
cytometry on peripheral blood T cells from healthy donors.   
A concentration-dependent binding of CyaA was observed, 
with the concentration giving half-maximum binding of   
5 nM (Fig. 1 A), in the range of that previously measured on 
myeloid cells (Guermonprez et al., 2001), suggesting the exis-
tence of a specific receptor for CyaA on human T cells. Simi-
lar  results  were  obtained  when  the  enzymatically  inactive 
variant of the toxin, CyaA-E5, was used (Fig. 1 B).
Consistent with the binding data, peripheral T cells ex-
posed to different concentrations of CyaA showed a concen-
tration-dependent accumulation of cAMP (Fig. 1 C). The 
half-maximal cAMP production occurred at a CyaA concen-
tration higher to that yielding half-maximal binding (25 nM). 
This difference could be accounted for by an active cAMP 
turnover in these cells, as demonstrated by the enhancement 
in cAMP production when cells were treated with CyaA in 
the presence of the phosphodiesterase inhibitor, 3-isobutyl-1-
methylxanthine (IBMX; unpublished data). cAMP produc-
tion in T cells exposed to CyaA was drastically reduced when 
cells were pretreated with adenylate cyclase-deficient mutant 
CyaA-E5 (Fig. 1 D), further supporting the notion that CyaA 
binds to a specific surface receptor.
can  also  form  cation-selective  pores  in  cell  membranes   
independently  of  translocation,  thereby  perturbing  ion   
homeostasis (Benz et al., 1994). CyaA triggers the sustained 
elevation of intracellular Ca2+ through cAMP-dependent, 
L-type  Ca2+  channels  (Fiser  et  al.,  2007;  Martín  et  al., 
2010). The suppressive activities of CyaA on immune cells 
have been largely ascribed to its capacity to increase intra-
cellular cAMP (Cheung et al., 2008; Paccani et al., 2008; 
Rossi Paccani et al., 2009; Martín et al., 2010), which acts 
as a potent immunosuppressant by interfering with the sig-
naling pathways initiated by immunoreceptors (Taskén and 
Stokka, 2006).
CyaA invades a variety of cell types through a mechanism 
involving receptor-independent binding to the cell surface 
and translocation of the catalytic domain through the plasma 
membrane (Ladant and Ullmann, 1999). In addition to this 
nonspecific interaction, CyaA binding to and intoxication of 
myeloid cells involves a high-affinity receptor identified as the 
M2 integrin, macrophage-1 antigen (Mac-1; CD11b/CD18; 
Guermonprez et al., 2001). Upon binding to Mac-1, CyaA 
induces its calpain-dependent migration to lipid rafts, where 
the cytosolic translocation may occur (Bumba et al., 2010). 
The interaction of CyaA with Mac-1 also depends on recog-
nition of its N-linked oligosaccharide chains, similar to other 
bacterial RTX that use 2 integrins to interact with their cel-
lular targets (Morova et al., 2008).
Although T cells do not express Mac-1, CyaA has pro-
found effects on purified T cells, acting as either immuno-
suppressor or immunomodulator in a concentration-dependent 
manner (Paccani et al., 2008; Rossi Paccani et al., 2009, 2011), 
suggesting the possibility that CyaA might interact with an 
alternative receptor expressed on the T cell surface. Here, we 
demonstrate that CyaA binds to T cells via the L2 integrin 
LFA-1 (CD11a/CD18). We also provide evidence that this 
Figure 1.  CyaA binding to T cells.  
(A and B) Flow cytometric analysis of CyaA or 
CyaA-E5 binding to peripheral blood T cells. 
The data are expressed as the difference be-
tween the MFI of cells incubated with CyaA, 
anti-CyaA antibodies (-CyaA), anti–rabbit Ig 
FITC-labeled secondary antibodies (-R), and 
the MFI of cells incubated with primary and 
secondary antibodies in the absence of CyaA 
(MFI). A representative concentration- 
response curve (n > 3) and FACS profiles 
(CyaA/CyaA-E5 45 nM) are shown. RFI, rela-
tive fluorescence intensity. (C) Quantification 
of cAMP production in lysates of peripheral 
blood T lymphocytes treated with different 
concentrations of CyaA for 30 min at 37°C. 
The results are expressed as fmol/106 cells 
(corresponding to 10 µg total protein). A rep-
resentative concentration-response curve (duplicate samples) is shown (n ≥ 2). (D) Quantification of cAMP production in lysates of peripheral blood  
T lymphocytes treated with 45 nM of CyaA or CyaA-E5. Where indicated, cells were preincubated for 5 min at 37°C with CyaA-E5 before addition of CyaA 
(n = 2). ***, P ≤ 0.001. (E) Flow cytometric analyses of CyaA (45 nM) binding to peripheral blood T cells, either resting or activated for the indicated times 
with anti-CD3 mAb. The data are expressed as fold increase of CyaA binding (measured as mean fluorescence intensity) in activated versus nonactivated 
samples (n ≥ 3). Error bars represent the SD. n indicates the number of independent experiments.JEM Vol. 208, No. 6 
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induce down-regulation of the putative receptor, although no 
variation in the levels of either the 7 integrin or the TCR–CD3 
complex was observed (Fig. S1 A). Together, the data suggest 
that CyaA binds to T cells via LFA-1.
The fact that CyaA binding was enhanced in activated   
T cells (Fig. 1 E) suggested the possibility that CyaA might 
interact preferentially with the open conformation of LFA-1. 
To assess this possibility we performed competition experi-
ments using the anti–LFA-1 mAb, mAb24, which recognizes 
an epitope exposed only in the open conformation (Landis   
et al., 1993). Exposure of the high-affinity conformation of 
LFA-1 was induced upon incubation in the presence of Mg2+ 
and  EGTA  (Landis  et  al.,  1993).  Preincubation  of  Mg2+/
EGTA-treated peripheral T cells with mAb24 resulted in a 
large reduction in CyaA binding (Fig. 2 D). Reciprocally, 
mAb24 binding was drastically reduced when cells were pre-
incubated with CyaA (Fig. 2 E). These data suggest that CyaA 
and mAb24 compete for overlapping binding sites on the 
open conformation of LFA-1. In contrast, neither the anti-
CD11a mAb HI111, which specifically recognizes the closed 
conformation of the integrin, nor an anti-CD18 mAb affected 
CyaA binding (Fig. S1 B). Moreover, binding of these mAbs 
was not altered when cells were preincubated with CyaA 
(Fig. S1 C). Hence, CyaA interacts preferentially with the 
open conformation of LFA-1.
LFA-1 is required for CyaA binding to and intoxication  
of T cells
The role of LFA-1 in CyaA binding to and intoxication of   
T cells was further assessed genetically using Jurkat T lymphoma 
cells, which are widely used as a model easily amenable to 
biochemical and genetic manipulation (Abraham and Weiss, 
2004). Jurkat cells bind CyaA and accumulate cAMP in the 
same range of concentrations as primary peripheral T cells in 
The interaction of CyaA with T cells is mediated by LFA-1
To further characterize the interaction of CyaA with its 
putative receptor on T cells, we compared CyaA binding to 
quiescent and activated T cells. Peripheral T cells were stimu-
lated at different times with an agonistic anti-CD3 mAb, and 
CyaA binding was measured by flow cytometry. Strikingly, 
TCR engagement elicited an immediate and strong increase 
in binding of CyaA (Fig. 1 E), as well as of CyaA-E5 (unpub-
lished data).
The extremely rapid increase in CyaA binding after TCR 
engagement suggests the possibility of a TCR-induced con-
formational change of a putative CyaA receptor, resulting in 
an increase of its affinity for the toxin. In T cells, the 2 inte-
grin LFA-1 undergoes such a process as the result of inside-
out signaling by the TCR (Evans et al., 2009; Shattil et al., 
2010). Based also on the fact that Mac-1, another 2 integrin, 
is the CyaA receptor on myeloid cells (Guermonprez et al., 
2001), we addressed the possibility that CyaA might bind to 
T cells via LFA-1.
Peripheral T cells were incubated on ice with an anti-
CD11a mAb (HI111) to allow binding, then shifted to 37°C 
to induce receptor-mediated internalization. The capacity of 
CyaA to bind to cells after LFA-1 had been down-regulated 
was then compared with untreated cells. A significant reduc-
tion in CyaA binding was observed under these conditions 
(Fig. 2 A). This effect was specific, as down-regulation of an 
unrelated cell surface receptor, the TCR–CD3 complex, did 
not affect CyaA binding (unpublished data). Similar results 
were obtained when the reciprocal experiment was performed. 
Cells were incubated on ice with CyaA, and then shifted to 
37°C to induce down-regulation of the putative receptor. CyaA 
was effectively internalized under these conditions (Fig. 2 B). 
Binding of the anti-CD11a mAb HI111was reduced when 
either CyaA (Fig. 2 B) or CyaA-E5 (Fig. 2 C) was used to 
Figure 2.  CyaA binds to T cells via  
LFA-1. (A) Flow cytometric analysis of bind-
ing of anti-CD11a mAb (HI111) or CyaA to 
peripheral T cells previously exposed to anti-
CD11a mAb at 37°C for 15 min to induce 
LFA-1 internalization (n = 3). (B and C) Flow 
cytometric analysis of binding of CyaA or 
mAbs directed against CD11a (HI111) or CD18 
to peripheral T cells previously exposed to  
45 nM CyaA (B) or CyaA-E5 (C) at 37°C for 
30 min to induce internalization of the CyaA 
receptor (n > 3 for CyaA and CD11a; n = 2 
for CD18; n = 2 for CyaA-E5). The results  
are expressed as the percentage binding to 
anti-CD11a mAb-treated (A) or CyaA/CyaA-
E5–treated (B and C) cells as compared  
with untreated cells (taken as 100%).  
(D and E) Flow cytometric analysis of CyaA 
(D) or mAb24 (E) binding to peripheral T cells 
previously incubated for 30 min at 37°C with Mg2+/EGTA to induce the open conformation of LFA-1 and then exposed to either mAb24 (D) or CyaA  
(E) before addition of CyaA or mAb24, respectively. RFI, relative fluorescence intensity. Data from two independent experiments, each with duplicate 
samples, are plotted in the histograms (levels of mAb24 or CyaA binding in Mg2+/EGTA treated cells taken as 100%). Error bars represent the SD.  
***, P ≤ 0.001; **, P ≤ 0.01; *, P ≤ 0.05. n indicates the number of independent experiments.1320 CyaA induces LFA-1 disengagement from the immune synapse | Baldari et al.
these results, TCR engagement resulted in an up-regulation 
of CyaA binding to Jurkat cells, similar to that found in pe-
ripheral T cells and, to a lower but significant extent, to the 
LFA-1+ J2.7wt cells, but not to the LFA-1 defective J2.7 
variant (Fig. 3 D). These results provide genetic evidence that 
LFA-1 is the CyaA receptor in T cells.
To assess the role of LFA-1 binding in T cell intoxication 
by CyaA, we compared the intracellular cAMP concentra-
tions in Jurkat and J2.7 Jurkat cells after incubation with 
CyaA. As opposed to Jurkat cells, where a robust increase in 
intracellular cAMP was detectable after exposure to CyaA, no 
significant enhancement in cAMP production was observed 
in J2.7 cells. This defect was reversed by CD11a reconstitu-
tion (Fig. 3 E), indicating that the specific binding of CyaA to 
LFA-1 enhances the translocation of the catalytic domain of 
the toxin into T cells.
LFA-1 is required for the immunosuppressive effects  
of CyaA on T cells
As previously reported, CyaA treatment results in a pro-
found impairment in TCR signaling, resulting in defective T cell 
activation and proliferation (Paccani et al., 2008). To deter-
mine whether this effect is dependent on CyaA binding to 
an LFA-1–dependent manner (Fig. S2, A–C). To address the 
contribution of LFA-1 to the CyaA intoxication process, we 
capitalized on the Jurkat variant J2.7, which does not express 
this integrin (Weber et al., 1997). These cells are genetically 
deficient for CD11a, and fail to express CD18 at the surface, 
as heterodimerization of the two subunits is required for de-
livery to the plasma membrane. As a control of specificity, we 
used a J2.7 transfectant reconstituted with CD11a to express 
LFA-1 (J2.7wt; Weber et al., 1997). An immunoblot analysis 
of CD11a expression in lysates of Jurkat cells and of the J2.7 
and J2.7wt sublines is shown in Fig. 3 A. As expected, no 
surface LFA-1 was detected in J2.7 cells, as measured by flow 
cytometry with anti-CD11a mAb, whereas significant levels 
of LFA-1 were present on J2.7wt cells (Fig. 3 B). The levels 
of surface CD11a in J2.7wt cells did not show a full corre-
spondence to the total levels observed by immunoblot, sug-
gesting that a significant proportion of recombinant CD11a 
might not reach the surface, possibly because it is overex-
pressed as compared with endogenous CD18. As shown in 
Fig. 3 C, CyaA failed to bind to the LFA-1–deficient Jurkat 
cells (J2.7), whereas significant binding was observed when 
LFA-1 expression was restored (J2.7wt), supporting the no-
tion that CyaA binds to T cells via LFA-1. Consistent with 
Figure 3.  LFA-1 is required for CyaA 
binding to and intoxication of T cells.  
(A) Immunoblot analysis of CD11a (mAb 27/
CD11a) expression in lysates of Jurkat cells, of 
the J2.7 variant lacking CD11a expression, 
and of J2.7 cells reconstituted with CD11a 
(J2.7.wt). A peripheral T cell lysate is in-
cluded for comparison. A control blot of the 
stripped filter is shown below. (B–D) Flow 
cytometric analysis of surface LFA-1 and CyaA 
binding to Jurkat, J2.7, and J2.7.wt cells. 
Cells were either unstimulated (B and C) or 
stimulated for 1 min with anti-CD3 mAb (D). 
The data are expressed as fold increase of 
CyaA binding in activated versus nonactivated 
samples (n = 3). RFI, relative fluorescence 
intensity. -CyaA, anti-CyaA antibodies; -R, 
anti–rabbit Ig FITC-labeled secondary anti-
bodies. (E) cAMP production in Jurkat, J2.7, 
and J2.7.wt cells incubated for 30 min at 
37°C either in the absence or in the presence of   
45 nM CyaA. The results, depicting the levels 
of cAMP in T cell lysates, are expressed as 
fmol/106 cells. Representative experiments, 
each performed on duplicate samples, are 
shown (n = 4). Error bars represent the SD.  
***, P ≤ 0.001; **, P ≤ 0.01. n indicates the 
number of independent experiments.  
(F) [3H]thymidine incorporation (cpm) in  
TT-specific T cells derived from 3 independent 
donors and stimulated with autologous APC 
pulsed with either 0.5 µg/ml TT or 1 µg/ml 
SEB/SEE (SAg). Where indicated, T cells were treated with 45 nM CyaA or CyaA-E5 before mixing with the APC. Alternatively, T cells were exposed to anti-
CD11a mAb (HI111) at 37°C for 15 min to induce LFA-1 internalization before addition of CyaA (preanti-CD11a). The histogram summarizes the data from 
triplicate samples from the three donors.JEM Vol. 208, No. 6 
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down-regulation, which showed an increase in the levels of 
surface LFA-1 beginning from 5 min after the 37°C shift 
(Fig. 4 B). These data suggest that, after binding to LFA-1 and 
receptor-mediated internalization, CyaA dissociates from LFA-1 
and remains associated to endosomal membranes, whereas 
LFA-1 recycles back to the cell surface, following its constitu-
tive recycling pathway (Caswell and Norman, 2006).
CyaA concentrates at the IS
When T cells encounter an APC bearing cognate MHC-
bound peptide, a highly organized interface known as the IS 
is formed between T cells and APCs. The IS acts as a dynamic 
platform where signals emanating from TCR, co-stimulatory 
receptors, and integrins are coordinated, integrated, and 
fine-tuned to trigger a transcriptional cascade that ultimately 
drives T cell activation and differentiation into effectors 
(Cemerski and Shaw, 2006; Fooksman et al., 2010). The ma-
ture IS is characterized by the specific partitioning of mem-
brane receptors, with the TCR and the co-stimulatory receptor 
CD28 clustered in the central region (central-supramolecular 
activation complex [c-SMAC]) and LFA-1 in a surrounding 
ring stabilized by F-actin (peripheral-supramolecular activation 
complex [p-SMAC]; Cemerski and Shaw, 2006; Fooksman   
et al., 2010). Correct localization of LFA-1 at the IS, and its 
interaction  with  its  counterreceptor  intercellular  adhesion 
molecule 1 (ICAM-1) on the APC, are essential for sustained 
signaling and T cell activation (Hogg et al., 2003; Fooksman 
et al., 2010).
The finding that CyaA binds to LFA-1 suggests that the 
toxin might interfere with IS formation by preventing the inter-
action of LFA-1 with ICAM-1. This hypothesis was tested on 
peripheral T cells conjugated with SEB/SEE-loaded APCs. 
To assess the impact of CyaA on IS formation in the absence 
LFA-1, we assessed the ability of CyaA to suppress T cell acti-
vation  when  LFA-1  had  been  down-regulated  using  an 
anti-CD11a mAb, using a key biological outcome, i.e., cell 
proliferation, as a readout. T cell activation was effectively 
suppressed by CyaA, but not by CyaA-E5, as shown by the 
profound impairment of the proliferative response to staphy-
lococcal enterotoxin B (SEB)/staphylococcal enterotoxin E 
(SEE), which was further demonstrated using tetanus toxoid 
(TT)-specific T cells generated from peripheral T cells from 
healthy donors, stimulated with TT-primed autologous APC 
(Fig. 3 F). The suppressive effect of CyaA on T cell prolifera-
tion was completely neutralized by cell pretreatment with the 
anti-CD11a mAb HI111 to induce LFA-1 down-regulation 
(Fig. 3 F), strongly supporting the notion that the immuno-
suppressive effects of CyaA on T cells are dependent on its   
interaction with LFA-1.
LFA-1 recycles to the T cell surface after targeting CyaA  
to a vesicular location
To address the dynamics of the association of CyaA with 
LFA-1, immunolocalization of the two proteins was performed 
at various times after exposure of the T cells to the toxin.   
Interestingly, at the early time points, CyaA displayed a signifi-
cant colocalization with LFA-1 at the cell surface, whereas at 
later  times  internalized  CyaA  appeared  to  dissociate  from 
LFA-1 (Fig. 4 A). By 30 min after the 37°C shift, CyaA was 
indeed found to be completely segregated to a vesicular com-
partment that was not stained by the anti–LFA-1 mAb. How-
ever, after a partial intracellular redistribution 5 and 15 min 
after CyaA down-regulation, LFA-1 was found to be preva-
lently associated to the plasma membrane by 30 min (Fig. 4 A). 
This was the result of rapid recycling, as measured in a time-
course analysis of surface CD11a after CyaA-dependent 
Figure 4.  LFA-1 rapidly recycles to the cell surface after CyaA internalization. (A) Immunofluorescence analysis of CyaA binding to peripheral  
T cells. Cells were either untreated or incubated with 45 nM CyaA at 4°C for 15 min, shifted to 37°C for the indicated times, and then fixed and stained. 
Representative confocal images are shown. Cells were co-stained with anti-CD11a mAb (HI111). Bar, 5 µm. (B) Flow cytometric analysis of surface CD11a 
in peripheral T cells. Cells were either untreated or incubated at 37°C for 30 min with CyaA (as described in Fig. 2 B) to induce internalization of the CyaA 
receptor (residual CyaA binding 23.3 ± 9%). After washing, cells were either immediately stained with anti-CD11a mAb or incubated at 37°C for the indi-
cated times before staining. The data are expressed as the percentage of CD11a binding on untreated cells (taken as 100%). Error bars represent the SD  
(n = 2). n indicates the number of independent experiments.1322 CyaA induces LFA-1 disengagement from the immune synapse | Baldari et al.
anti-CD11a  mAb  and  an  anti-CD3  mAb,  respectively. A 
functional IS could be observed in antigen-specific conju-
gates, as indicated by clustering of both LFA-1 (Fig. 5, A and C) 
of the immunosuppressive effect of cAMP, we used the cata-
lytically inactive CyaA-E5 mutant. IS assembly was moni-
tored by confocal imaging of LFA-1 and the TCR, using 
Figure 5.  CyaA clusters to the IS and impairs the sustained polarization of LFA-1 to the IS. Immunofluorescence analysis of CyaA and CD11a (A) 
or CD3 (B) in conjugates of peripheral T cells and antigen-pulsed APC (SAg), incubated at 37°C for 15 min. Conjugates formed in the absence of antigen 
are shown on the left part of A. Where indicated, T cells were incubated for 15 min on ice with 45 nM of either CyaA or CyaA-E5 before washing and 
mixing with the APC. Median optical sections are shown. Bars, 5 µm. (C) Relative fluorescence at the T cell–APC contact site compared with the remaining 
T cell area (CyaA, CyaA-E5) or T cell membrane (CD11a; relative recruitment index; n conjugates ≥ 20) in conjugates incubated at 37°C for 15 min.  
(D) Immunofluorescence analysis of CyaA/CyaA-E5 and CD11a in conjugates of peripheral T cells and antigen-pulsed APC, prepared as described above 
and incubated at 37°C for 5 min. (E) Relative CD11a fluorescence at the T cell–APC contact site compared with the remaining T cell membrane (CD11a) in 
conjugates incubated at 37°C for 5 min (n conjugates ≥ 20). (F) Immunoblot analysis with anti–ZAP-70 phosphospecific antibodies of lysates of conju-
gates of peripheral T cells (untreated or treated with CyaA as in A) and antigen-pulsed APC incubated at 37°C for 15 min. A control blot of the stripped 
filter is shown below. A representative blot is shown out of three independent experiments. Error bars represent the SD. ***, P < 0.001.JEM Vol. 208, No. 6 
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Consistent with these results, activation of ZAP-70, which is 
a key initiator protein tyrosine kinase (Wang et al., 2010), was 
impaired in antigen-specific conjugates when T cells were 
preexposed to CyaA (Fig. 5 F). Collectively, these data suggest 
that CyaA induces the disengagement of LFA-1 from the   
mature IS through its cAMP-elevating activity, which impairs 
and the TCR (Fig. 5 B) at the contact surface with the APC. 
When T cells were preincubated with CyaA-E5 in conditions 
that allowed its binding, but not its internalization (i.e., 4°C), 
and then mixed with antigen-pulsed APCs, CyaA-E5 was 
found to cluster at the IS (Fig. 5, A–C), which is consistent 
with the notion that the toxin is targeted to the IS by LFA-1. 
However, CyaA-E5 did not affect the assembly of a func-
tional IS, as assessed by TCR (Fig. 5 B) and LFA-1 (Fig. 5, A 
and C) clustering.
Interestingly, CyaA-E5 appeared to concentrate largely in 
vesicles polarized beneath the LFA-1–enriched membrane 
patch at the IS (Fig. 5 A). Consistent with the data shown in 
Fig. 4 A, an intracellular vesicular localization of the toxin was 
also observed in T cells when conjugates were formed in the 
absence of antigen (Fig. 5 A); however, under these conditions 
the vesicles displayed a homogeneous intracellular distribu-
tion. In both cases, the localization of LFA-1 appeared to be 
largely membrane-associated, although LFA-1–positive vesi-
cles could be observed beneath the plasma membrane. These 
data suggest that, after its recruitment to the IS through LFA-1, 
CyaA dissociates from the integrin and is internalized in an 
endosomal compartment.
CyaA impairs the sustained clustering of LFA-1 at the IS
The finding that CyaA-E5 clusters at the IS with LFA-1 
suggests that the toxin may parasitize the LFA-1–ICAM-1 
interaction to concentrate at the IS, where it would be   
ideally positioned to suppress signaling through its cAMP- 
elevating activity. To test this hypothesis, similar experiments 
were performed using catalytically active CyaA. CyaA was 
found to cluster at the contact site between T cell and APC, 
similar to CyaA-E5 (Fig. 5, A–C). However, whereas TCR 
recruitment to the IS was not affected by CyaA (Fig. 5 B), 
the  localization  of  LFA-1  appeared  dramatically  altered 
compared with control antigen-specific conjugates, with a 
diffuse  distribution  of  LFA-1  immunostaining  over  the   
T cell surface (Fig. 5, A and C). This effect could also be ob-
served at lower CyaA concentrations, down to 5 nM (Fig. S3). 
Because both CyaA-E5 and CyaA effectively bind to T cells, 
these data suggest that the failure of LFA-1 to cluster at the 
IS is caused by the cAMP-elevating activity of the toxin. 
However, this raises the question of how CyaA is recruited 
to the IS.
To provide an explanation to the different subcellular   
localization of CyaA and LFA-1 at the IS compatible with the 
observation that the toxin binds to T cells through LFA-1, we 
hypothesized that CyaA as a complex with LFA-1 might be 
rapidly delivered to the IS, where it could trigger cAMP ac-
cumulation that would then lead to redistribution of LFA-1 
out of the IS. To assess this possibility, we looked at the initial 
stages of IS formation, which involve the rapid movement of 
LFA-1 to the contact site with the APC. As shown in Fig. 5 
(D and E), LFA-1 rapidly clustered with CyaA at the forming 
IS. This pattern of localization was lost in the mature IS, with 
CyaA remaining at the contact site with the APC while LFA-1 
was redistributed over the plasma membrane (Fig. 5, A and C). 
Figure 6.  The sustained clustering of LFA-1 at the IS is negatively 
regulated by cAMP/PKA. (A) Immunofluorescence analysis of CD11a in 
conjugates of peripheral T cells and antigen-pulsed APC (SAg). Where 
indicated, 100 µM 8-CPT was added to T cells after mixing with the APC 
(B). Alternatively, T cells were preincubated at 37°C for 1 h in the presence 
of 20 µM H-89 or 56 nM KT5720, and then washed and transferred to ice, 
added with CyaA (45 nM), and further incubated on ice for 15 min before 
washing and mixing with the APC. Conjugates were incubated at 37°C for 
15 min. Median optical sections are shown. Bars, 5 µm. The histograms 
show the relative CD11a fluorescence at the T cell–APC contact site com-
pared with the remaining T cell membrane (relative recruitment index;  
n conjugates ≥ 20). Error bars represent the SD. ***, P < 0.001.1324 CyaA induces LFA-1 disengagement from the immune synapse | Baldari et al.
CyaA promotes talin release from the IS
The actin cytoskeleton undergoes an extensive reorganiza-
tion during IS formation. At the mature IS, LFA-1 is tethered 
to the actin cytoskeleton underlying the p-SMAC by the ac-
tin adaptor, talin, which results in the stabilization of the T cell 
interaction with the APC (Evans et al., 2009). Talin interacts 
with LFA-1 as the result of inside-in signaling by the TCR, 
which results in the generation of a binding site in the cyto-
solic tail of the 2 integrin. Talin binding is required for LFA-1 
tethering to F-actin, and it also triggers a conformational 
change in the extracellular domain that increases its affinity 
for ICAM-1 (Evans et al., 2009).
To assess the potential perturbation by CyaA of the inter-
action of LFA-1 with the actin cytoskeleton, talin, and F-actin 
were immunostained in antigen-specific conjugates. As ex-
pected, a significant proportion of the large cytosolic pool of 
talin clustered at the IS together with F-actin (Fig. 7 A). A 
similar distribution was observed when cells were exposed to 
CyaA-E5 before conjugate formation. In striking contrast, a 
signaling, and underscore a link between cAMP and LFA-1 
clustering at the IS.
The  impact  of  cAMP  in  the  sustained  clustering  of   
LFA-1 at the mature IS was assessed by administration of the 
nonhydrolysable cAMP analogue 8-CPT-cAMP (8-CPT) to 
antigen-specific T cell–APC conjugates during IS formation. 
8-CPT treatment of antigen-specific conjugates resulted in a 
diffuse LFA-1 distribution over the whole plasma membrane, 
similar to that found in CyaA-treated cells (Fig. 6 A), sup-
porting the notion that cAMP impairs the stable clustering 
of LFA-1 at the mature IS. To further investigate this issue, 
we tested the effect of two different PKA inhibitors, H89 
and  KT5720,  on  the  CyaA-dependent  disengagement  of 
LFA-1 from the IS. Both H89 and KT5720 largely reversed 
the effects of CyaA, as shown by the fact that LFA-1 re-
mained clustered at the mature IS (Fig. 6 B). Together, these 
data indicate that cAMP impairs the stability of the IS by 
inducing redistribution of LFA-1 through a cAMP/PKA- 
dependent mechanism.
Figure 7.  CyaA promotes the premature dissipation of talin from the IS. Immunofluorescence analysis of talin and F-actin (phalloidin; A) or talin 
and CyaA/CyaA-E5 (B) in conjugates of peripheral T cells and antigen-pulsed APC (SAg). Where indicated, T cells were incubated for 15 min on ice with  
45 nM of either CyaA or CyaA-E5 before washing and mixing with the APC. (C) Histogram showing the relative talin fluorescence at the T cell–APC contact 
site compared with the remaining T cell area (relative recruitment index; n conjugates ≥ 20) in conjugates incubated at 37°C for 15 min. (D) Immuno-
fluorescence analysis of talin and CyaA in conjugates of peripheral T cells and antigen-pulsed APC, prepared as described above. Conjugates were incubated 
for 5 min at 37°C. (E) Histogram showing the relative talin fluorescence at the T cell–APC contact site compared with the remaining T cell area (relative 
recruitment index; n conjugates ≥ 20) in conjugates incubated for 5 min at 37°C. Error bars represent the SD. ***, P < 0.001.JEM Vol. 208, No. 6 
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in CyaA-treated T cells (Fig. 7, D and E), suggesting that 
cAMP disrupts the interaction of LFA-1 with talin after their 
initial clustering at the IS. In migrating cells, calpain-mediated 
cleavage of either talin or the integrin  tail is one of the 
principal mechanisms whereby LFA-1 disengages from the 
actin cytoskeleton (Franco et al., 2004; Flevaris et al., 2007). 
However, the calpain inhibitor calpeptin did not affect the 
CyaA-induced relocalization of LFA-1 out of the IS (Fig. S4 A). 
Moreover, neither CyaA nor 8-CPT promoted talin cleavage 
(Fig. S4 B), ruling out calpain-mediated cleavage of either the 
integrin tail or talin as the mechanism underlying LFA-1 re-
distribution out of the IS.
The CyaA-induced disengagement of LFA-1  
from the IS is dependent on the microtubule cytoskeleton
The fact that CyaA and LFA-1 co-localize at the early stages 
of IS formation but display a distinct localization at the ma-
ture IS, with CyaA localized in an endomembrane compart-
ment and LFA-1 homogenously distributed on the plasma 
membrane (Fig. 5), together with the finding that LFA-1 re-
cycles back to the surface after internalization in CyaA-treated 
cells (Fig. 4), strongly suggests that the disengagement of 
LFA-1 from the IS may involve its recycling to the plasma 
membrane. To assess this possibility, we tested the impact of 
pharmacological disruption of the microtubule cytoskeleton, 
which is essential for endosome recycling (Soldati and Schliwa, 
2006), on the CyaA-dependent disengagement of LFA-1 
from the IS, as well as on talin dissipation. To avoid interfering 
with IS assembly, conjugates were allowed to form for 5 min 
(at which time LFA-1 clustered at the IS; Fig. 5, D and E) be-
fore addition of the microtubule poison colchicine. Strikingly, 
colchicine treatment fully reversed the dissipating effects of 
CyaA on both LFA-1 (Fig. 9 A) and talin (Fig. 9 B). Colchi-
cine treatment also prevented the redistribution of LFA-1 in-
duced by 8-CPT (Fig. S5). These data support the notion   
that the redistribution of LFA-1 induced by CyaA through 
its cAMP-elevating activity involves LFA-1 recycling to the 
plasma membrane.
DISCUSSION
Integrins have emerged as targets of election of many bacte-
rial and viral pathogens (Hauck et al., 2006; Stewart and 
Nemerow, 2007). The interaction with an integrin confers to 
the pathogen two advantages, which are crucial to the initial 
phases of infection, i.e., adhesion to target cells, which facilitates 
colonization, and internalization, which protects the patho-
gen from immune attack. In some instances, as in the case of 
B. pertussis CyaA, the virulence factor has an enzymatic activ-
ity with the potential to subvert central processes in target 
cells. Similar to other RTX (Morova et al., 2008), CyaA inter-
acts with a 2 integrin, which has been identified as Mac-1 
for macrophages and neutrophils (Guermonprez et al., 2001) 
and in this work as LFA-1 for T lymphocytes. Although nu-
merous in vitro studies have established that CyaA can enter 
a wide variety of cell types and even interact with artificial 
bilayers in a receptor-independent fashion (Gray et al., 1999; 
diffuse cytosolic localization of talin was observed in CyaA- 
treated T cells engaged in antigen-specific conjugates (Fig. 7, 
A–C), despite the fact that the pattern of F-actin staining at 
the IS was not affected (Fig. 7 A). This indicates that the   
altered localization of talin was dependent on the cAMP-
elevating activity of the toxin. In support of this notion, treat-
ment of T cells with 8-CPT before conjugate formation also 
resulted in a diffuse cytosolic localization of talin (Fig. 8 A). 
Moreover, the effect of CyaA was reversed by treatment of 
T cells with the PKA inhibitors H89 and KT5720, as shown 
by the sustained clustering of talin at the IS under these con-
ditions (Fig. 8 B).
Similar to the results obtained with LFA-1, talin was cor-
rectly recruited to the IS during the early steps of IS assembly 
Figure 8.  The sustained enrichment of talin at the IS is negatively 
regulated by cAMP/PKA. Immunofluorescence analysis of talin in con-
jugates of peripheral T cells and antigen-pulsed APC. Where indicated, 
100 µM 8-CPT was added to T cells after mixing with the APC (A). The 
percentage of conjugates with talin enrichment at the IS in the presence 
or absence of 8-CPT was 26 and 74%, respectively. Alternatively, T cells 
were preincubated at 37°C for 1 h in the presence of 20 µM H-89 or 56 
nM KT5720, and then washed, transferred to ice, added with 45 nM CyaA, 
and incubated on ice for an additional 15 min before washing and mixing 
with the APC (B). Conjugates were incubated at 37°C for 15 min. Median 
optical sections are shown. Bar, 5 µm. The histogram shows the relative 
talin fluorescence at the T cell–APC contact site compared with the re-
maining T cell area (relative recruitment index; n conjugates ≥ 20). Error 
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surface of T cells. The preferential interaction of CyaA with 
the open conformation of LFA-1 is likely to underlie the ob-
servation that, the effective down-regulation of CyaA binding 
in CyaA-treated cells notwithstanding (Fig. 2 B), the total 
levels of surface LFA-1 are not reduced to the same extent. 
Reciprocally, the partial down-regulation of total LFA-1 in-
duced by the anti-CD11a mAb (Fig. 2 A) is expected to result 
in the internalization of only part of the small proportion of 
the open conformation form, which will therefore affect to a 
moderate extent CyaA binding, as actually observed.
We have previously reported that CyaA can potently sup-
press T cell activation by preventing initiation and propaga-
tion of TCR signaling through its cAMP elevating activity 
(Paccani et al., 2008; Rossi Paccani et al., 2009). Our data 
highlight a new, additional mechanism of immunosuppres-
sion by CyaA. By interacting with LFA-1 without affecting 
its clustering to the p-SMAC, CyaA acquires the means to 
reach the membrane patch at the IS where the signaling cascades 
triggered by the TCR and other key receptors (e.g. CD4/
CD8, CD28, and LFA-1) are fine-tuned and integrated to 
drive the complex process of T cell activation. cAMP produc-
tion at this location is expected to permit the highly effective 
targeting of these pathways. In this respect, it should be under-
lined that, although CyaA is internalized by endocytosis, it 
remains associated to a vesicular compartment localized be-
neath the IS. It can be hypothesized that the production of 
cAMP by CyaA at this IS-proximal localization may result in 
Eby et al., 2010), expression of Mac-1 on macrophages has 
been shown to greatly enhance the intracellular delivery of 
the adenylate cyclase domain of CyaA and toxin-induced cell 
death (Guermonprez et al., 2001; El-Azami-El-Idrissi et al., 
2003; Hewlett et al., 2006). Similarly, binding of CyaA to 
LFA-1 on T cells is critical for cell intoxication, as assessed by: 
(a) the saturable, concentration-dependent increase of intra-
cellular cAMP accumulation (Fig. 1 C); (b) the capacity of the 
enzymatically inactive variant CyaA-E5 to compete with CyaA 
(Fig. 1 D); and (c) the failure of CyaA to intoxicate the LFA-
1 negative T cells (Fig. 3 E). Furthermore, suppression of   
T cell proliferation by CyaA is crucially dependent on its   
interaction with LFA-1 (Fig. 3 F). It is noteworthy that we 
detected significant CyaA binding to the thymoma line 
EL4, comparable to other T cells used in this study (un-
published data), which is at variance with the previous study 
by Guermonprez et al. (2001). These authors might have 
  underevaluated toxin binding to EL4 cells as compared with 
that found with the different myeloid lines they examined. 
Alternatively, the low CyaA binding to EL4 cells reported by 
Guermonprez et al. (2001), could be accounted for by a rela-
tively low level of surface LFA-1 in their EL4 subline or a low 
proportion of the active conformation of LFA-1 in their ex-
perimental conditions.
Indeed, our findings strongly suggest that CyaA interacts 
preferentially with the open conformation of LFA-1, which 
represents only a minor fraction of the integrin present at the 
Figure 9.  The CyaA-dependent redistribution of LFA-1 from the IS requires an intact microtubule cytoskeleton. Immunofluorescence analysis 
of LFA-1 and CyaA (A) or talin and CyaA (B) in conjugates of peripheral T cells and antigen-pulsed APC (SAg). Where indicated, T cells were incubated for 
15 min on ice with CyaA before washing and mixing with the APC. 20 µM Colchicine was added 5 min after mixing T cells and APC to allow formation of 
conjugates and LFA-1 clustering at the IS. Conjugates were incubated at 37°C for an additional 10 min. Median optical sections are shown. Bars, 5 µm. 
The effectiveness of the colchicine treatment on the integrity of the microtubule cytoskeleton was checked by immunofluorescence analysis with anti– 
-tubulin mAb (unpublished data). Histograms showing the relative LFA-1 (A) or talin (B) fluorescence at the T cell–APC contact site compared with the 
remaining T cell area (relative recruitment index; n conjugates ≥ 20) are shown. Error bars represent the SD. ***, P < 0.001.JEM Vol. 208, No. 6 
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partner, resulting in talin displacement. An alternative attrac-
tive possibility, which takes into account the fact that the 
active conformation of LFA-1 is very transient (Seo et al., 2001) 
is that, after inhibition of TCR signaling by PKA, LFA-1 would 
rapidly return to its closed conformation, unable to bind talin. 
This would result in talin dissipation and disengagement of 
LFA-1 from the actin filaments at the p-SMAC.
Based on the findings presented in this study, we propose 
the following model (Fig. S6). When a T cell encounters an 
APC carrying cognate antigen, CyaA is rapidly targeted to 
the forming IS through its interaction with LFA-1 without 
affecting IS formation, including LFA-1 clustering at the   
p-SMAC and its tethering to the actin cytoskeleton by talin. 
Once at the IS, the local membrane environment, highly en-
riched in lipid rafts, might facilitate the translocation of the 
catalytic domain of the toxin across the membrane bilayer into 
the cytosol. Whether LFA-1 directly contributes to the deliv-
ery of the catalytic domain across the membrane remains un-
known at present, although the mechanism may be akin to the 
Mac-1–dependent internalization process found in macro-
phages (Guermonprez et al., 2001; Bumba et al., 2010). CyaA 
is then internalized into a vesicular compartment that remains 
polarized beneath the IS membrane. Because only a minor 
proportion of LFA-1 can be observed in this location, we hy-
pothesize that CyaA rapidly dissociates from LFA-1 in an early 
endocytic compartment, from which LFA-1 recycles back to 
the plasma membrane. Impaired inside-out TCR signaling, 
caused by cAMP accumulation, will result in a failure to main-
tain the open conformation of the remaining LFA-1 mole-
cules clustered at the p-SMAC. As a consequence, talin will 
dissociate from LFA-1, resulting in its disengagement from 
the underlying actin filaments and its redistribution from the 
IS. Because this event is prevented by pharmacological dis-
ruption of the microtubule cytoskeleton (Fig. 8), the data in-
dicate that LFA-1 exploits its known recycling pathway to 
redistribute to the plasma membrane. The defect in LFA-1 
clustering at the IS, together with the ability of cAMP to in-
hibit signaling by the TCR and other surface receptors, will 
result in the effective suppression of T cell activation.
The fact that CyaA can act both as an immunosuppressant 
and an immunomodulator is intriguing. Although immuniza-
tion of mice by co-administration of CyaA with antigen in 
the footpad has been shown to prime the development of 
Th2 and Th17 cells (Ross et al., 2004; Boyd et al., 2005; 
Dunne et al., 2010), both the immunosuppressive and immuno-
modulatory activities of the toxin are likely to coexist in the 
physiological setting of infection. These differential effects 
may be related to distinct responses of immune cells upon ex-
posure to different toxin concentrations that might be present 
in vivo, although, to date, the exact concentrations of CyaA 
released by B. pertussis during the course of the colonization 
of the respiratory tract are not known. High toxin concentra-
tions in the vicinity of the pathogen during active infection 
may block the activation of immune cells, as strongly supported 
by the finding that the bacterial burden is lower in the lungs 
of mice infected with a CyaA-defective B. pertussis mutant 
the local accumulation of cAMP at levels sufficient to trigger 
efficient LFA-1 disengagement from the IS even at toxin con-
centrations that increase to a small extent the global cAMP 
levels. This notion is supported by the concentration-response 
experiments shown in Fig. S3, where LFA-1 clustering at the 
IS was found to be significantly impaired by 5 nM CyaA, 
which triggers only a modest increase in cAMP (Fig. 1 C). 
We have previously reported that cAMP production is rapidly 
turned on in T cells treated with CyaA, reaching maximal 
levels at early time points (30 min) and remaining almost sta-
tionary for several hours (Paccani et al., 2008; Rossi Paccani 
et al., 2009). This sustained cAMP synthesis in T cells, despite 
their ability to rapidly catabolize this nucleotide because of 
their high phosphodiesterase activity (unpublished results), indi-
cates that CyaA remains active long after it has been internal-
ized into the cell, which would allow effective targeting of the 
signaling pathways emanating from the IS.
Although CyaA can affect TCR signaling at multiple steps, 
beginning with activation of the initiating kinase, Lck (Rossi 
Paccani et al., 2009), IS formation appears to proceed normally 
in the presence of CyaA (Fig. 5, B and D). This could be ac-
counted for by the fact that CyaA-mediated cAMP accumula-
tion is delayed with respect to IS assembly (Rossi Paccani et al., 
2009). The immunosuppressive activity of CyaA at the IS in-
volves instead a dramatic alteration in the long-lasting cluster-
ing of LFA-1 at the p-SMAC, which is essential to stabilize the 
interaction between T cell and APC on which sustained sig-
naling and T cell activation crucially depend (Evans et al., 2009; 
Dustin and Cooper, 2000). This notion is supported by the 
finding that the defect in LFA-1 retention at the mature IS can 
be reproduced by exogenous administration of 8-CPT (Fig. 6 A). 
The rescue of LFA-1 clustering to the IS in CyaA-treated   
T cells by the PKA inhibitors H89 and KT5720 (Fig. 6 B) not 
only further strengthens the link between cAMP signaling and 
LFA-1 mobility but also implicates PKA as the main cAMP 
target in the control of this process.
The mechanisms governing LFA-1 clustering to the IS 
have been partially elucidated. In resting T cells, LFA-1 exists 
in a low-affinity state that allows for probing of APCs for spe-
cific antigen without stopping. TCR engagement triggers an 
inside-out signaling cascade, involving Rap1 activation through 
ADAP/SKAP55, which promotes an increase in the affinity 
of LFA-1 for ICAM-1 and LFA-1 clustering to the forming 
IS, where it becomes tethered to the actin cytoskeleton by talin. 
However, the mechanisms responsible for the subsequent dis-
engagement of LFA-1 from the IS remain elusive. In migrat-
ing cells, cleavage of talin or the integrin  tail by calpain, 
phosphorylation, or dephosphorylation events, and recruit-
ment of competitors of talin binding to the integrin have 
been proposed as mechanisms by which the link between   
integrins and the actin cytoskeleton is disrupted (Calderwood, 
2004; Harburger and Calderwood, 2009). Our data provide 
evidence that LFA-1 disengagement and talin release from 
the IS are regulated by PKA. Although calpain does not ap-
pear to be implicated in this process (Fig. S4), PKA may pro-
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supplemented with 7.5% FCS and 2 mM CaCl2, added with CyaA, and   
incubated at 37°C for 15 min before activation. Alternatively, cells were pre-
incubated with 100 µM 8-CPT before activation. When required, cells were 
preincubated with 280 µM calpeptin at 37°C for 1 h before the addition of 
CyaA. None of the aforementioned treatments affected cell viability, as 
assessed by Trypan blue exclusion.
Cells (106/sample) were lysed in 1% Triton X-100 in 20 mM Tris-HCl, 
pH 8.0, 150 mM NaCl in the presence of a protease inhibitor cocktail, and 
equal amounts of proteins from each sample (measured using a kit from 
Thermo Fisher Scientific) were used for immunoblots. Immunoblotting was 
performed using primary antibodies and peroxidase-labeled secondary anti-
bodies according to the manufacturer’s instructions and a chemiluminescence 
detection kit (Thermo Fisher Scientific). All blots were reprobed with load-
ing control antibodies after stripping. Prestained molecular mass markers   
(Invitrogen) were included in each gel.
cAMP measurements. Intracellular cAMP was quantitated by enzyme-
linked immunoassay kit (Biotrak EIA; GE Healthcare) according to the 
manufacturer’s instructions. For these experiments, cells were treated with CyaA 
for 30 min in the presence of hexokinase as previously described (Guermonprez 
et al., 2001). At the end of the treatment, cells were washed and lysed in the 
lysis reagent included in the kit. In competition experiments, cells were pre-
treated with CyaA-E5 for 5 min at 37°C before addition of CyaA. In some 
experiments, 0.5 mM IBMX was included during CyaA treatment to block 
the activity of endogenous phosphodiesterases.
Flow cytometry and proliferation assays. Surface CD3, CD11a (mAb 
HI111), CD18, and 7 integrin were quantitated by flow cytometry using 
fluorochrome-labeled mAb (CD3) or unlabeled mAb followed by FITC-labeled 
secondary antibodies. For integrin down-regulation assays, cells were shifted 
to 37°C 15 min before labeling.
To measure CyaA binding, 5 × 105 cells were incubated with different 
concentrations of CyaA in serum-free RPMI 1640 (supplemented with 2 mM 
CaCl2, which is required for CyaA entry into the cells) in 96-well culture 
plates for 30 min on ice. Cells were then washed and incubated on ice with 
anti-CyaA antibody for 30 min. After washing, cells were stained with FITC-
conjugated secondary antibodies. For Cya down-regulation assay, cells were 
shifted to 37°C 30 min before labeling. For competition experiments, cells 
were preincubated on ice for 30 min with anti-CD11a (mAb HI111), anti-
CD11b, or anti-CD18 mAb before addition of CyaA, or vice versa.
For experiments involving mAb24, the open conformation of LFA-1 
was induced by incubation for 30 min at 37°C in Hepes buffer (20 mM 
Hepes, 140 mM NaCl, and 2 mg/ml glucose, pH 7.4) in the presence of 1 mM 
MgCl2/EGTA, as previously described (Landis et al., 1993). Cells were then 
added, with either mAb24 or CyaA, and incubated at 37°C for 30 min to   
allow binding. After washing, cells were shifted to ice, and subjected to indirect 
labeling before processing for flow cytometry. For competition experiments, 
after the incubation step in Hepes buffer supplemented with MgCl2/ EGTA 
to induce the open conformation, cells were mixed with either mAb24 or 
CyaA (45 nM), incubated at 37°C for 30 min, and then washed and added 
with CyaA or mAb24, respectively. After 30 min incubation at 37°C, cells 
were processed for flow cytometry as described above.
To analyze LFA-1 recycling after CyaA-induced down-regulation, cells 
were incubated for 30 min on ice with 45 nM CyaA, washed, and incubated 
on ice with anti-CyaA antibody for 30 min. After washing, cells were incu-
bated for 30 min at 37°C to induce receptor internalization. Cells were then 
washed and either immediately processed for flow cytometry or incubated at 
37°C for further 15–60 min before labeling for CD11a.
Cells were analyzed by flow cytometry using a FACScan flow cytometer 
(BD). Data were acquired using CellQuest and analyzed and plotted using 
FlowJo (Tree Star). The binding data were deduced from the mean fluores-
cence intensity (MFI) and expressed as MFI = (MFI value of cells incubated 
with CyaA)  (MFI value of cells incubated without CyaA).
For proliferations, assays 105 T cells of each TT-induced line (see the 
Cells, antibodies, reagents, and toxins section) were stimulated with 0.5 µg/ml 
(Khelef et al., 1992). Lower concentrations that may be found 
distant from the infection sites or during the resolution phase 
of the infection could instead modulate both directly and in-
directly the differentiation of helper T cells primed not only 
by B. pertussis, but also by other antigens present at that time. 
A full characterization of the pleiotropic effects of CyaA on 
both innate and adaptive immune cells will help understand-
ing how B. pertussis subverts the host immune response.
MATERIALS AND METHODS
Cells, antibodies, reagents, and toxins. Cell lines included Jurkat T cells 
and Raji B-cells, both of human origin, as well as the CD11a-deficient Jurkat 
variant J2.7 (provided by C. Weber, Aachen University, Aachen, Gernmany) 
and a J2.7 line stably transfected with the CD11a cDNA to reconstitute 
LFA-1 expression (provided by O. Schwartz [Institut Pasteur, Paris France] 
and C.E. Hioe [NYU Medical Center, New York, NY]; Weber et al., 1997). 
T cells were purified from buffy coats from anonymous healthy donors using 
the StemSep Human T cell enrichment kit (Voden Medical Instruments 
SpA). To generate antigen-specific T cell lines, PBMCs from three TT-reactive 
donors were seeded (1.5 × 106 per well) in 24-well flat-bottomed plates in   
2 ml RPMI 1640 medium supplemented with 5% human serum, and then 
stimulated with 0.5 µg/ml TT for 5 d. All lines were supplemented with 
20 U/ml IL-2 on day 6 and at 3-d intervals thereafter. On day 12, T cell blasts 
were used for proliferation assays.
Anti-CD3 mAb was purchased from Santa Cruz Biotechnology, Inc. 
Anti-CD11a (Hl111), -CD11b, and -CD18 mAbs were obtained from eBio-
science Inc. Anti-talin mAb was obtained from Sigma-Aldrich. Anti-CD11a 
(27/CD11a) mAb was purchased from BD. Anti–phospho-ZAP-70 mAb was 
obtained from Cell Signaling Technology. Anti-actin mAb was purchased 
from Millipore. Fluorochrome-labeled anti-CD3 mAb was obtained from 
BD and Alexa Fluor 488–labeled cholera toxin B was obtained from Invitro-
gen. mAb24 (Landis et al., 1993) was purchased from Abcam. Unlabeled sec-
ondary antibodies were purchased from ICN Pharmaceuticals Inc. and 
peroxidase-labeled antibodies were obtained from GE Healthcare. Alexa 
Fluor 488– and Alexa Fluor 555–labeled secondary antibodies were obtained 
from Invitrogen, FITC-conjugated anti–mouse Ig was obtained from DAKO, 
and FITC-conjugated anti–rabbit Ig was obtained from Sigma. IgG from 
OKT3 (American Type Culture Collection) hybridoma supernatants were 
purified on Mabtrap (GE Healthcare) and titrated by flow cytometry. Anti-
CyaA antibodies were raised in rabbits upon immunization with the purified 
full-length protein.
CyaA and the enzymatically inactive variant CyaA-E5 (resulting from a 
LG dipeptide insertion between D188 and I189 in the catalytic core of the 
enzyme) were expressed in E. coli and purified to near homogeneity by previ-
ously established procedures (Karimova et al., 1998). The specific activity of 
CyaA, measured as previously described (Ladant et al., 1992), was >500 µmol 
cAMP/min/mg, whereas CyaA-E5 had no detectable enzymatic activity. In 
both preparations, the endotoxin content, determined using a LAL assay 
(QCL-1000 kit; Lonza), was below 0.5 EU/µg protein.
SEB and SEE were purchased from Toxin Technology; Cell Tracker Blue 
was purchased from Invitrogen; poly-l-lysine, colchicine, 8-CPT-cAMP, and 
IBMX were purchased from Sigma-Aldrich; and H89, calpeptin, and KT5720 
were obtained from Merck. Human recombinant IL-2 and TT were provided 
by Chiron Corp.
Cell  activations,  lysis,  and  immunoblots. Activation  by TCR–CD3 
cross-linking for the binding experiments was performed by incubating   
Jurkat cells or T cells with saturating concentrations of anti-CD3 mAb and 
50 µg/ml secondary antibodies for 30 s–60 min at 37°C, as previously described 
(Boncristiano et al., 2003). The immunoblot analysis of ZAP-70 phosphory-
lation was carried on lysates of antigen-specific T cell–APC conjugates (see 
Immunofluorescence microscopy), incubated at 37°C for 15 min. For the 
immunoblot analyses, cells were plated at 5 × 106 cells/ml in RPMI 1640 JEM Vol. 208, No. 6 
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